Skip to main content
. 2022 Feb 2;15:335–345. doi: 10.2147/IDR.S350570

Table 1.

Clinical Characteristics of the Included Patients

Characteristics All (n = 289) Confirmed LNTB (n = 61) Probable LNTB (n = 192) Non-LNTB (n = 36)
Age (year, mean ± SD) 39.7±19.0 47.7±20.7 36.4±16.4 44.8±23.1
Male (n, %) 127 (43.9) 25 (41.0) 81 (42.2) 21 (58.3)
HIV positive (n, %) 1 (0.3) 1 (1.6) 0 (0.0) 0 (0.0)
Symptoms (n, %)
 Fever 76 (26.3) 19 (31.1) 49 (25.5) 8 (22.2)
 Night sweat 40 (13.8) 17 (27.9) 21 (10.9) 2 (5.6)
 Pain 74 (25.6) 21 (34.4) 32 (16.7) 21 (58.3)
 Dysphagia 9 (3.1) 4 (6.6) 3 (1.6) 2 (5.6)
 Weigh loss 38 (13.1) 19 (31.1) 17 (8.9) 2 (5.6)
LN sites (n, %)
 Cervical LN 264 (91.3) 57 (93.4) 174 (90.6) 33 (91.7)
 Axillary LN 23 (8.0) 4 (6.6) 16 (8.3) 3 (8.3)
 Inguinal LN 2 (0.7) 0 (0.0) 2 (1.0) 0 (0.0)
Other sites involved of TB (n, %)
 Pulmonary TB 122 (42.2) 26 (42.6) 90 (46.9) 6 (16.7)
 Pleural TB 13 (4.5) 1 (1.6) 11 (5.7) 1 (2.8)
 Specimen type (n, %)
 CNB 191 (66.1) 48 (78.7) 117 (60.9) 26 (72.2)
 Tissue 98 (33.9) 13 (21.3) 75 (39.1) 10 (27.8)
 Pathological antacid staining (+) (n, %) 13 (4.5) 13 (21.3) 0 (0.0) 0 (0.0)

Abbreviations: LNTB, lymph node tuberculosis; HIV, human immunodeficiency virus; LN, lymph node; TB, tuberculosis; CNB, core needle biopsy.